You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Legacy Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LEGACY PHARMA, and what generic and branded alternatives to LEGACY PHARMA drugs are available?

LEGACY PHARMA has seven approved drugs.

Summary for Legacy Pharma

US Patents:	0
Tradenames:	6
Ingredients:	5
NDAs:	7

Drugs and US Patents for Legacy Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Legacy Pharma	BETAPACE AF	sotalol hydrochloride	TABLET;ORAL	021151-003	Feb 22, 2000	AB	RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-002	Aug 29, 2002	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Legacy Pharma	BETAPACE AF	sotalol hydrochloride	TABLET;ORAL	021151-006	Apr 2, 2003		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Legacy Pharma	BETAPACE AF	sotalol hydrochloride	TABLET;ORAL	021151-001	Feb 22, 2000	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Legacy Pharma	BETAPACE AF	sotalol hydrochloride	TABLET;ORAL	021151-002	Feb 22, 2000	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Legacy Pharma	BETAPACE	sotalol hydrochloride	TABLET;ORAL	019865-004	Oct 30, 1992		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Legacy Pharma	ALA-SCALP	hydrocortisone	LOTION;TOPICAL	083231-001	Approved Prior to Jan 1, 1982		RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Legacy Pharma

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-001	Aug 29, 2002	6,455,557	⤷ Sign Up
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-003	Aug 29, 2002	6,455,557	⤷ Sign Up
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-002	Aug 29, 2002	6,455,557	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for LEGACY PHARMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	2 mg, 4 mg and 6 mg	➤ Subscribe	2007-08-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.